Revolutionary FDA Approval Marks Medical Milestone
Startup Clairity has achieved a groundbreaking milestone in healthcare technology, securing FDA approval for the agency’s first artificial intelligence tool specifically designed to predict five-year breast cancer risk from…
The National Institutes of Health (NIH) is actively seeking comprehensive industry feedback on developing its groundbreaking artificial intelligence strategy, marking a pivotal moment in healthcare technology advancement. This strategic initiative represents the federal government’s…
Continue Reading
Challenges exist with the adoption of Fast Healthcare Interoperability Resources (FHIR) within analytics, including the difficulty in transforming complex data structures, and performance issues when querying large datasets in their native JSON or XML…
Continue Reading
🎧 Subscribe to The Pulse by Wharton Digital Health on Apple, Spotify, Substack, or Twitter for more conversations with the leaders reshaping health tech.Obesity and weight loss are among the most significant and complex challenges…
Continue Reading
The Segment Anything Model (SAM) was fine-tuned on the EchoNet-Dynamic dataset and evaluated on external transthoracic echocardiography (TTE) and Point-of-Care Ultrasound (POCUS) datasets from CAMUS (University Hospital of St Etienne) and Mayo Clinic (99…
Continue Reading
Under-resourced hospitals face a big artificial intelligence adoption learning curve, but it’s surmountable if they can keep up with rapidly advancing analytics and AI tools in an industry increasingly turning to automation to lower…
Continue Reading
In acute ischemic stroke due to large-vessel occlusion (AIS-LVO), late-window endovascular thrombectomy (EVT) decisions depend on penumbra-to-core (P:C) mismatch from computed tomographic perfusion (CTP). We developed multiple machine learning (ML) models to predict P:C…
Continue Reading
This paper proposes a “True Lifecycle Approach” (TLA) towards governing healthcare AI. The TLA governance model embeds core healthcare law principles—like informed consent, liability, and patient rights—throughout AI’s development, deployment, and use. Unlike narrow…
Continue Reading
What You Should Know:
– Mission Bio, a leader in single-cell multiomics solutions for precision medicine, today announced the launch of its Single-Cell Genotype and Targeted Gene Expression assay, expanding the capabilities of its Tapestri Platform…
Continue Reading
Large language models (LLMs) are transforming the landscape of healthcare research, yet their role in qualitative analysis remains underexplored. This study compares human-led and LLM-assisted approaches to analyzing cancer patient narratives, using 33 semi-structured…
Continue Reading
